NASDAQ:INSM

Insmed Stock Predictions

Healthcare > Biotechnology

Buy INSM

*Your capital is at risk

$103.86

+0.130 (+0.125%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

INSM Prediction Chart

INSM Predictions History

Latest community submissions for INSM.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
Lennon Pierce @LennonPierce.133214	Jan 9, 2020	$26.70 +3.45%	$25.81	X	96.55%
GoldenNugget Pro	May 7, 2019	$31.10 +10.04%	$28.26	X	89.96%
NameNotImportant Pro	May 6, 2019	$30.44 -5.44%	$32.19	X	94.56%
NameNotImportant Pro	May 2, 2019	$28.74 -3.33%	$29.73	X	96.67%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INSM with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INSMED

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by